DISCOUNT ZERTIFIKAT - NOVARTIS N Share Price

Certificat

DE000ME1REB1

Real-time Bid/Ask 13:59:04 24/06/2024 BST
88.09 EUR / 88.1 EUR -0.10% Intraday chart for DISCOUNT ZERTIFIKAT - NOVARTIS N
Current month+2.87%
1 month+3.78%
Date Price Change
24/06/24 88.15 -0.03%
21/06/24 88.18 -0.15%
20/06/24 88.31 -0.33%
19/06/24 88.6 0.00%
18/06/24 88.6 +0.69%

Delayed Quote Börse Stuttgart

Last update June 24, 2024 at 11:05 am

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Morgan Stanley
WKN ME1REB
ISINDE000ME1REB1
Date issued 09/10/2023
Maturity 20/09/2024 (88 Days)
Parity 1 : 1
Emission price 83.72
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 88.6
Lowest since issue 80.49
Spread 0.01
Spread %0.01%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
105.1 USD
Average target price
110.3 USD
Spread / Average Target
+4.97%
Consensus